Skip to main content
Caplight Logo









Artelus

Artelus

Private
BangaloreHealthcare & Life Scienceshttps://artelus.com/

Last Round

Grant

Jun 25, 2026

Total Funding Raised

$142,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Artelus is a healthtech company that develops AI-powered diagnostic screening tools for the early detection of diseases such as diabetic retinopathy, tuberculosis, and various cancers.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Computer Vision, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

medical imaging AIdiagnostic softwareretinal screeningAI diagnosticsautomated screeningcomputer visionclinical decision supportdiabetic retinopathy detectionmedtechAI radiologyhealthtechmammography analysistuberculosis screeningB2B SaaSfundus camera

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Artelus Comparables

Compare Artelus with similar companies based on industry and business-model similarity.

Artelus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Airdoc
79%
DeepTek
78%
Dectrocel Healthcare and Research
78%

Artelus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 25, 2026
GrantMar 11, 2019

Artelus Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 91% MoM.

  • Jun 25, 2026

    $42K grant received from Department for Promotion of Industry and Internal Trade and Roche Pharma India.

Artelus Filings

Explore SEC and related filing metadata, where available.

Artelus filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Artelus's valuation, stock price, and market status.

Is Artelus a public or private company?

Artelus is a private company.

What is the current stock price of Artelus?

Artelus is a private company with no public stock price. Caplight tracks Artelus's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Artelus worth (valuation)?

Valuation information for Artelus is not publicly available.

Can I buy Artelus stock?

Artelus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Artelus's last funding round?

Artelus's most recent funding round was Grant on June 25, 2026.

Who are the main investors in Artelus?

Key investors in Artelus include Department for Promotion of Industry and Internal Trade.

Will Artelus IPO soon?

No public IPO plans have been announced for Artelus.

How can I track Artelus secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Artelus's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangalore
Employee Range24
Year Founded2015
Last FundingJun 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?